Convenient Synthesis of Some Novel Pyridazinone‐Bearing Triazole Moieties

[1]  Walid Fathalla,et al.  Domino synthesis of quinazolin-4-yl thioureido alkanoates , 2018, Chemical Papers.

[2]  Walid Fathalla,et al.  Convenient domino synthesis of quinazolin-4(3H)-ylidene carbothioamides and carbamothioates , 2017 .

[3]  I. Ali,et al.  A novel method for heterocyclic amide–thioamide transformations , 2017, Beilstein journal of organic chemistry.

[4]  M. Hashemzadeh,et al.  Triazole antifungals: a review. , 2015, Drugs of today.

[5]  E. Kuepeli,et al.  Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives. , 2009, European journal of medicinal chemistry.

[6]  K. Abouzid,et al.  Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity. , 2008, Bioorganic & medicinal chemistry.

[7]  I. Ali,et al.  Convenient synthesis of 1-substituted-4-methyl-5-oxo [1,2,4]triazolo[4,3-a]quinazolines , 2007 .

[8]  I. Ali,et al.  Efficient synthesis of 1-substituted-4-phenyl-1, 4-dihydro-5H-tetrazole-5-thione and (1-phenyl-1H-tetrazol-5-yl)thioacetyl derivatives , 2007 .

[9]  S. A. El‐Hawash,et al.  Synthesis of Some New Quinoxalines and 1,2,4‐Triazolo[4,3‐a]‐quinoxalines for Evaluation of in vitro Antitumor and Antimicrobial Activities , 2006, Archiv der Pharmazie.

[10]  A. Karaburun,et al.  Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. , 2004, European journal of medicinal chemistry.

[11]  O. Lozach,et al.  New derivatives of pyrrolo[3,4-d]pyridazinone and their anticancer effects. , 2004, Farmaco.

[12]  E. Sotelo,et al.  Pyridazine derivatives. Part 33: Sonogashira approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones☆ , 2003 .

[13]  T. Kinoshita,et al.  Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity. , 1999, Journal of medicinal chemistry.

[14]  M. Hann,et al.  Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines. , 1993, Journal of medicinal chemistry.

[15]  J. Calleja,et al.  Pyridazine derivatives. XI: Antihypertensive activity of 3-hydrazinocycloheptyl[1,2-c]pyridazine and its hydrazone derivatives. , 1993, Journal of pharmaceutical sciences.

[16]  R. Schmidt,et al.  Synthesis and activity optimization of herbicidal substituted 4-aryl-1,2,4-triazole-5(1H)-thiones , 1992 .

[17]  S. Goldstein,et al.  Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group. , 1991, The American journal of cardiology.

[18]  B. Refouvelet,et al.  Anticonvulsant activity of 3-oxo-5-substituted benzylidene-6-methyl-(4H)-2-pyridazinylacetamides and 2-pyridazinylacetylhydrazides. , 1990, Chemical & pharmaceutical bulletin.

[19]  W. Moos,et al.  Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activit , 1987, Journal of medicinal chemistry.

[20]  Theodor Curtius.  Synthetische Versuche mit Hippurazid , 1902 .

[21]  M. Siegmund,et al.  Epr-und emissionsspektroskopische untersuchungen an chinoxalinen und s-triazolo-[4,3-a]chinoxalinen , 1978 .